CASE REPORT: RUXOLITINIB AS FIRST-LINE THERAPY FOR SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PATIENTS WITH AIDS

Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS

BackgroundHemophagocytic lymphohistiocytosis (HLH) is a fatal immunological syndrome resulting from excessive production of inflammatory cytokines.The conventional therapies for HLH, which are based on cytotoxic agents, are not always efficacious and safe, especially in patients with severe immunodeficiency.Ruxolitinib, a strong inhibitor of Janus

read more


State-of-the-art review on various mathematical approaches towards solving population balanced equations in pharmaceutical crystallization process

Crystallization is an important process, which possesses an undeniable role in many chemical industries.In recent years, significant endeavors have been made to increase the efficiency of this process via designing novel crystallizers.Development of numerical models and their efficient solutions is known as an important approach to justify the beha

read more